The CRISPR technology market is experiencing dynamic growth and transformation due to its revolutionary potential in gene editing and genetic engineering. The increasing adoption of CRISPR in research and development activities, particularly in the fields of healthcare and agriculture, is driving market expansion. The technology's ability to precisely modify DNA sequences with high efficiency and cost-effectiveness has attracted significant investment and collaborations. Additionally, advancements in CRISPR-associated enzymes and delivery systems are enhancing its therapeutic applications, including potential treatments for genetic disorders and cancers. However, challenges such as off-target effects, ethical considerations, and intellectual property disputes pose regulatory and commercial hurdles. Overall, the CRISPR technology market is projected to witness significant growth fueled by ongoing research, collaborations, and the potential for ground breaking medical and agricultural applications.
The global CRISPR Technology Market was valued at US$ 2,251.2 Mn in 2021 and is forecast to reach a value of US$ 7,715.6 Mn by 2028 at a CAGR of 19.2% between 2022 and 2028.
Top Companies in the CRISPR Technology Industry:
1. Merck KGaA
Merck KGaA, founded in 1668, is a multinational pharmaceutical, chemical, and Life Sciences Company headquartered in Darmstadt, Germany. It operates in more than 66 countries worldwide, including the United States, China, and India. In September 2022, Merck KGaA announced the expansion of its CRISPR product portfolio through the acquisition of a leading gene editing Technology Company, further strengthening its presence in the CRISPR market.
2. Thermo Fisher Scientific
Thermo Fisher Scientific, established in 2006 through the merger of Thermo Electron Corporation and Fisher Scientific, is based in Waltham, Massachusetts, United States. The company provides scientific research services, instruments, and consumables globally, operating in over 180 countries. Thermo Fisher Scientific has made significant advancements in CRISPR technology, including the development of CRISPR-based gene editing kits and tools, offering researchers innovative solutions for genetic engineering.
3. Origene Technologies, Inc.
Origene Technologies, Inc., founded in 1996, is headquartered in Rockville, Maryland, United States. The company specializes in molecular biology research tools and services, including CRISPR-based gene editing solutions. Origene operates in multiple countries worldwide, serving researchers and scientists in academia, pharmaceuticals, and biotechnology industries. Recent developments in the field of CRISPR technology by Origene Technologies, Inc. are not available at the moment.
4. New England Biolabs
New England Biolabs (NEB), established in 1974, is based in Ipswich, Massachusetts, United States. NEB is a leading provider of recombinant and native enzymes for molecular biology research, including CRISPR-related products and services. The company operates globally, serving the scientific community in over 150 countries. In February 2023, New England Biolabs introduced a novel CRISPR enzyme variant, expanding its portfolio of gene editing tools and enabling improved precision and efficiency in genetic manipulation.
5. GenScript
GenScript, founded in 2002, is headquartered in Piscataway, New Jersey, United States. It is a global biotechnology company offering a comprehensive range of life science research tools and services, including CRISPR-based gene editing solutions. GenScript operates in multiple countries worldwide, serving researchers in academia, pharmaceuticals, and healthcare industries. In July 2022, GenScript announced a strategic collaboration to develop next-generation CRISPR technologies for advanced genome editing applications.
6. GeneCopoeia, Inc.
GeneCopoeia, Inc., established in 2004, is based in Rockville, Maryland, United States. The company focuses on developing innovative tools and technologies for gene expression analysis and functional genomics, including CRISPR-related products. GeneCopoeia operates globally, providing solutions to researchers in academia and biopharmaceutical industries. Recent developments in the field of CRISPR technology by GeneCopoeia, Inc. are not available at the moment.
7. Cellecta, Inc.
Cellecta, Inc., founded in 2006, is headquartered in Mountain View, California, United States. The company specializes in functional genomics technologies and services, including CRISPR-based gene knockout and screening platforms. Cellecta operates globally, serving researchers in academia and biopharmaceutical industries. In November 2022, Cellecta announced the expansion of its CRISPR screening services, offering customized, high-throughput gene knockout screening capabilities to support drug discovery and functional genomics research.
8. Agilent Technologies, Inc.
Agilent Technologies, Inc., established in 1999, is based in Santa Clara, California, United States. The company is a global leader in life sciences, diagnostics, and applied chemical markets, providing a wide range of instruments, consumables, and software solutions. Agilent Technologies operates in over 100 countries worldwide, including the United States, China, and Germany. In April 2023, Agilent Technologies announced the launch of a new CRISPR-based gene synthesis technology, enabling faster and more accurate DNA assembly for synthetic biology applications.
9. PerkinElmer, Inc. (Horizon Discovery Ltd.)
PerkinElmer, Inc., founded in 1937, is headquartered in Waltham, Massachusetts, United States. The company offers a broad range of scientific instruments, software, and services for diagnostics, life sciences, and environmental markets. PerkinElmer operates in more than 150 countries globally, including the United States, China, and India. In January 2023, PerkinElmer completed the acquisition of Horizon Discovery Ltd., a leading provider of gene editing and gene modulation technologies, expanding its capabilities in CRISPR-based research tools and services.
10. Danaher Corporation (Integrated DNA Technologies)
Danaher Corporation, established in 1969, is headquartered in Washington, D.C., United States. The company operates in various industries, including life sciences, diagnostics, and environmental solutions. Through its subsidiary, Integrated DNA Technologies (IDT), Danaher is actively involved in the development and commercialization of CRISPR-based products, serving researchers globally. IDT offers a wide range of CRISPR genome editing tools, synthetic DNA, and gene expression solutions, supporting diverse applications in molecular biology and genomics research.
Definition- CRISPR technology is a revolutionary gene editing tool that allows precise modification of DNA sequences. It utilizes RNA-guided enzymes to target specific genes, enabling researchers to edit, add, or delete genetic material with high efficiency and accuracy.
